BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 23929208)

  • 1. Nonclassical hedgehog-GLI signaling and its clinical implications.
    Shevde LA; Samant RS
    Int J Cancer; 2014 Jul; 135(1):1-6. PubMed ID: 23929208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonclassical activation of Hedgehog signaling enhances multidrug resistance and makes cancer cells refractory to Smoothened-targeting Hedgehog inhibition.
    Das S; Samant RS; Shevde LA
    J Biol Chem; 2013 Apr; 288(17):11824-33. PubMed ID: 23508962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitogen-activated protein kinases and Hedgehog-GLI signaling in cancer: A crosstalk providing therapeutic opportunities?
    Rovida E; Stecca B
    Semin Cancer Biol; 2015 Dec; 35():154-67. PubMed ID: 26292171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cooperative integration between HEDGEHOG-GLI signalling and other oncogenic pathways: implications for cancer therapy.
    Pandolfi S; Stecca B
    Expert Rev Mol Med; 2015 Feb; 17():e5. PubMed ID: 25660620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic inhibition of Hedgehog-GLI signaling in cancer: epithelial, stromal, or stem cell targets?
    Ruiz i Altaba A
    Cancer Cell; 2008 Oct; 14(4):281-3. PubMed ID: 18835029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the hedgehog signal transduction pathway at the level of GLI inhibits neuroblastoma cell growth in vitro and in vivo.
    Wickström M; Dyberg C; Shimokawa T; Milosevic J; Baryawno N; Fuskevåg OM; Larsson R; Kogner P; Zaphiropoulos PG; Johnsen JI
    Int J Cancer; 2013 Apr; 132(7):1516-24. PubMed ID: 22949014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of Hedgehog signalling in cancer.
    Marini KD; Payne BJ; Watkins DN; Martelotto LG
    Growth Factors; 2011 Dec; 29(6):221-34. PubMed ID: 21875383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The intrahepatic signalling niche of hedgehog is defined by primary cilia positive cells during chronic liver injury.
    Grzelak CA; Martelotto LG; Sigglekow ND; Patkunanathan B; Ajami K; Calabro SR; Dwyer BJ; Tirnitz-Parker JE; Watkins DN; Warner FJ; Shackel NA; McCaughan GW
    J Hepatol; 2014 Jan; 60(1):143-51. PubMed ID: 23978713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expressions of sonic hedgehog, patched, smoothened and Gli-1 in human intestinal stromal tumors and their correlation with prognosis.
    Yoshizaki A; Nakayama T; Naito S; Wen CY; Sekine I
    World J Gastroenterol; 2006 Sep; 12(35):5687-91. PubMed ID: 17007023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement and targeted intervention of dysregulated Hedgehog signaling in osteosarcoma.
    Lo WW; Wunder JS; Dickson BC; Campbell V; McGovern K; Alman BA; Andrulis IL
    Cancer; 2014 Feb; 120(4):537-47. PubMed ID: 24151134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone acetyltransferase PCAF is required for Hedgehog-Gli-dependent transcription and cancer cell proliferation.
    Malatesta M; Steinhauer C; Mohammad F; Pandey DP; Squatrito M; Helin K
    Cancer Res; 2013 Oct; 73(20):6323-33. PubMed ID: 23943798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The presence of primary cilia in cancer cells does not predict responsiveness to modulation of smoothened activity.
    Spann AL; Yuan K; Goliwas KF; Steg AD; Kaushik DD; Kwon YJ; Frost AR
    Int J Oncol; 2015 Jul; 47(1):269-79. PubMed ID: 25997440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Canonical and noncanonical Hedgehog/GLI signaling in hematological malignancies.
    Aberger F; Kern D; Greil R; Hartmann TN
    Vitam Horm; 2012; 88():25-54. PubMed ID: 22391298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-canonical activation of GLI transcription factors: implications for targeted anti-cancer therapy.
    Lauth M; Toftgård R
    Cell Cycle; 2007 Oct; 6(20):2458-63. PubMed ID: 17726373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting GLI factors to inhibit the Hedgehog pathway.
    Infante P; Alfonsi R; Botta B; Mori M; Di Marcotullio L
    Trends Pharmacol Sci; 2015 Aug; 36(8):547-58. PubMed ID: 26072120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HH/GLI signalling as a new therapeutic target for patients with oral squamous cell carcinoma.
    Yan M; Wang L; Zuo H; Zhang Z; Chen W; Mao L; Zhang P
    Oral Oncol; 2011 Jun; 47(6):504-9. PubMed ID: 21536478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hedgehog-GLI signaling inhibition suppresses tumor growth in squamous lung cancer.
    Huang L; Walter V; Hayes DN; Onaitis M
    Clin Cancer Res; 2014 Mar; 20(6):1566-75. PubMed ID: 24423612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting hedgehog signaling pathway in pediatric tumors: in vitro evaluation of SMO and GLI inhibitors.
    Arnhold V; Boos J; Lanvers-Kaminsky C
    Cancer Chemother Pharmacol; 2016 Mar; 77(3):495-505. PubMed ID: 26781311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hedgehog Signaling and Truncated GLI1 in Cancer.
    Doheny D; Manore SG; Wong GL; Lo HW
    Cells; 2020 Sep; 9(9):. PubMed ID: 32957513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WIP1 phosphatase modulates the Hedgehog signaling by enhancing GLI1 function.
    Pandolfi S; Montagnani V; Penachioni JY; Vinci MC; Olivito B; Borgognoni L; Stecca B
    Oncogene; 2013 Oct; 32(40):4737-47. PubMed ID: 23146903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.